A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer
A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer
Recruiting · NCT07505771 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer | Solid Malignancies | Recruiting | Phase 1 | 2026-10-07 | NCT07505771 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Immunome, Inc. | 5 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Excel Diagnostics and Nuclear Oncology Center | Houston | United States | 5 |
| NovaCure LLC | Miami | United States | 1 |
| Stanford University School of Medicine | Palo Alto | United States | 6 |
| University of Texas - MD Anderson Cancer Center | Houston | United States | 8 |
| XCancer Research Network / Dothan Hematology & Oncology | Dothan | United States | 1 |